On a day marked by a broad sell-off across the technology sector, IBM has stood out as a notable bright spot. The stock, which has behaved like a roller coaster over the past year, recently came off its highs but is now staging a recovery. The catalyst for this morning's strength is a pair of analyst upgrades that have helped the shares avoid the wider tech decline, sending the stock up roughly 4.4% to 4.5% to trade around $263.38 (referenced at points as 263 and change).
A Double Boost: Two Upgrades, Not One
The notable feature of this move is that IBM received not one but two positive analyst notes on the same morning, giving the stock a double boost.
JP Morgan: Upgrade to Overweight
The first upgrade came from JP Morgan, whose analyst raised the stock to overweight from neutral, with a new price target of $291, up from $270. Even accounting for the morning's upward move (the stock was trading at $263.38), this target implies meaningful upside.
The core reasoning behind the upgrade is greater confidence in software acceleration during the second half of the year. The analyst was explicit that software remains the central thesis for owning the stock, writing: "We previously noted software is the primary driver of IBM stock. This remains the case as the higher value software business mix continues to grow."
JP Morgan did acknowledge a potential weak spot — possible softness in Red Hat Enterprise Linux, tied to weaker server growth across the broader industry. However, the analyst argued that this weakness would be offset by five distinct factors:
1. Red Hat and OpenShift migration tailwinds — ongoing migration activity supporting the business.
2. OpenShift strength aided by growing AI-driven container adoption — AI workloads boosting demand for containerization.
3. Automation reacceleration — renewed momentum in IBM's automation offerings.
4. Contribution from data following the recent Confluent acquisition — new data capabilities adding to results.
5. Transaction processing acceleration related to current mainframe cycles — strength tied to mainframe demand.
On the mainframe point, JP Morgan noted that IBM is about to lap some very difficult comparisons from its recent Z17 mainframe cycle. While this dynamic is well known to the market, the analyst regards it as less relevant to the long-term story, viewing the software business as the primary growth engine through the back half of the year.
The note also flagged the possibility of multiple expansion, should IBM, in the analyst's words, "gain incremental traction as a substantial AI infrastructure beneficiary."
Morgan Stanley: Raised Target, Equal-Weight Rating
The second note came from Morgan Stanley, which raised its price target to $267, up from $225. This new target sits just barely above the current trading level, implying more modest but still positive upside. Notably, Morgan Stanley kept an equal-weight rating on the shares rather than upgrading the rating itself.
Despite the equal-weight stance, Morgan Stanley's commentary was bullish in tone, suggesting investors should "scoop up the stock" and stating their belief that it is ready to outperform. The firm's key argument concerns server demand: it observed that enterprise server demand is proving far more inelastic than expected despite significant price increases, attributing this resilience to compute shortages, refresh activity, and growing AI-related infrastructure needs.
Morgan Stanley further argued that Street estimates for both 2026 and 2027 look too low — a direct quote. On that basis, the firm raised its EPS estimates by roughly five to six percent for compute-exposed names. IBM is one of those names, alongside Dell and HPE, which were also mentioned in the same note.
Putting it in context, IBM is down more than 11% year to date, but Morgan Stanley's view is that it is time to buy because the firm sees only upside from current levels.
An Example Options Trade on IBM
Beyond the analyst commentary, an options strategist offered a practical way to express a view on the name. His take was more measured than the "nothing but upside" framing — he was skeptical that there is purely upside from here — but he agreed that the downside may be muted.
His reasoning rested on several supports for the stock:
- The stock has major support around the $235 level.
- It has been heavily sold off this year ("taken out to the woodshed").
- It carries a decent dividend yield.
- It has beaten earnings for four straight quarters, which means the long-awaited multiple expansion may finally come into play.
Given these factors, his approach would be to be a buyer on any sort of dip, rather than an aggressive buyer at current levels. The specific structure he described is a bull put spread expiring July 17th:
- Sell the $235 puts (collecting premium).
- Buy the $230 puts as a hedge.
- This collects roughly 70 cents of credit, equating to about a 16% return on risk.
- It provides a downside cushion of over 25 points.
He framed this as a market in which patience may finally be rewarded going forward, particularly after the day's price action. The trade is designed to take advantage of still-elevated implied volatility — IV remains above the 50th percentile level — while not requiring an aggressive directional commitment.
The Bottom Line
IBM's resilience on an otherwise steep down day for tech rests on a clear, consistent narrative: its higher-value software business is the primary growth driver, increasingly augmented by AI-related infrastructure and server demand that is proving more durable than the market expected. JP Morgan's outright upgrade to overweight and Morgan Stanley's raised target — even at an equal-weight rating — both point to the same conclusion, namely that after an 11%-plus year-to-date decline, the risk-reward has tilted toward the upside, with measured, dip-buying strategies offering a way to participate while cushioning against the still-present downside.
